4th Quarter - Report
TODD STRATEGY GROUP for UCB, INC.
Firm
Client
Income
$50,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 16, 2022 | $50,000 | Replaced |
| 4th Quarter - Report (this page) | Jan 19, 2022 | $50,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues regarding FDA PDUFA procedures in COVID. COVID-19 Response.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL EDATTEL | — |
| DANIEL M TODD | — |
Medicare/Medicaid MMM
General Medicare/Medicaid Issues. Prescription Drug Payment Reform. Medicare prescription drug reimbursement. H.R.5376 - Build Back Better Act. H.R.3684 - Infrastructure Investment and Jobs Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL EDATTEL | Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg |
| DANIEL M TODD | Senior Health Counsel, Senate Finance Committee |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.